PREIMPLANTATION GENETIC DIAGNOSIS MARKET ANALYSIS

Key Developments

• In May 2024, Takara Bio USA, Inc., a subsidiary of Takara Bio Inc., has launched the Lenti-X Transduction Sponge, a novel microfluidic transduction enhancer for lentivirus-mediated gene delivery. This innovative product simplifies the process with a walkaway workflow, achieving high transduction efficiency across cell types. President & CEO Carol Lou highlighted its potential to revolutionize viral transduction methods, offering a reliable and non-toxic alternative to chemical enhancers, thereby streamlining research and reducing costs.
• In April 2024, GenEmbryomics Limited, a trailblazer in advanced genetic testing services for embryos, and Progenesis Inc, a top provider of preimplantation genetic testing for in vitro fertilization (IVF), have announced a transformative partnership aimed at expanding access to state-of-the-art reproductive technologies.
• In June 2023, Kindbody, a prominent fertility clinic network and provider of family-building benefits for employers, has launched Kindlabs, its new genetic testing division. This addition integrates genomics into Kindbody's comprehensive care model, enhancing patient services. Kindlabs operates a state-of-the-art reference laboratory spanning 8,000 square feet in Secaucus, NJ.